What Changed, and What Didnt In late 2023, the FDA moved 19 widely used peptides to its Category 2 list, effectively banning compounding pharmacies from preparing them
Introduction This paper attempts to review, in a particular way, the stable gastric pentadecapeptide BPC 157 (for review see, i.e., [1,2,3,4,5,6]) and its effects on striated, smooth, and heart muscles
It regulates cytokines (TNF-, IL-6), decreases swelling, and limits immune-cell overactivity
Out with Gout By Hannah McDuffie, Public Affairs Officer Gout affects more than 9 million Americans and 52% are uncomfortable talking about it
Impurities in one compound can interact unpredictably with other compounds in a stack, making quality assurance non-negotiable